A mathematical model of tumour angiogenesis, regulated by vascular endothelial growth factor and the angiopoietins

Journal of Theoretical Biology

Volumn 229, Issue 4, 2004, Pages 435-454

  Plank, M J ^a,c   Sleeman, B D ^a   Jones, P F ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CANTERBURY   (New Zealand)

Author keywords

Angiogenesis; Angiopoietin; Endothelium; Tumour; VEGF

Indexed keywords

ANGIOPOIETIN; VASCULOTROPIN;

TUMOR;

ANGIOGENESIS; ARTICLE; CANCER THERAPY; MATHEMATICAL MODEL; MICROSCOPY; PRIORITY JOURNAL; PROPHYLAXIS; QUALITATIVE ANALYSIS; TUMOR VASCULARIZATION;

ANGIOPOIETINS; ENDOTHELIUM, VASCULAR; HUMANS; MATHEMATICS; MODELS, BIOLOGICAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 3042713269     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtbi.2004.04.012     Document Type: Article

References (72)

1. Acker T., Beck H., Plate K.H. Cell type specific expression of vascular endothelial growth factor and angiopoietin-1 and -2 suggests an important role of astrocytes in cerebellar vascularisation. Mech. Dev. 108:2001;45-57
2. Anderson A.R.A., Chaplain M.A.J. Continuous and discrete mathematical models of tumour-induced angiogenesis. Bull. Math. Biol. 60:1998;857-900
3. Anderson A.R.A., Sleeman B.D., Young I.M., Griffiths B.S. Nematode movement along a chemical gradient in a structurally heterogeneous environment. 2. Theory. Fund. Appl. Nematol. 20:1997;165-172
4. Anderson A.R.A., Chaplain M.A.J., Newman E.L., Steele R.J.C., Thompson A.M. Mathematical modelling of tumour invasion and metastasis. J. Theor. Med. 2:2000;129-154
5. Arakelyan L., Merbl Y., Daugulis P., Ginosar Y., Vainstein V., Selitser V., Kogan Y., Harpak H., Agur Z. Multi-scale analysis of angiogenic dynamics and therapy. Preziosi L. Cancer modelling and simulation. 2003;183-220 CRC press, London. (Chapter 7)
6. Ashara T., Chen D., Takahashi T., Fujikawa K., Kearney M., Magner M., Yancopoulos G.D., Isner J.M. Tie-2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularisation. Circ. Res. 83:1998;233-240
7. Ausprunk D.H., Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumour angiogenesis. Microvasc. Res. 14:1977;53-65
8. Balding D., McElwain D.L.S. Mathematical modelling of tumour-induced capillary growth. J. Theor. Biol. 114:1985;53-73
9. Beck H., Acker T., Wiessner C., Allegrini P.R., Plate K.H. Expression of angiopoietin-1, angiopoietin-2 and Tie receptors after middle cerebral artery occlusion in the rat. Am. J. Pathol. 157:2000;1473-1483
10. Byrne H.M., Chaplain M.A.J. Mathematical models for tumour angiogenesis. numerical simulations and nonlinear wave solutions Bull. Math. Biol. 57:1995;461-486
11. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:1996;435-439
12. Chaplain M.A.J., Stuart A.M. A model mechanism for the chemotactic response of endothelial cells to tumour angiogenesis factor. IMA J. Math. Appl. Med. Biol. 10:1993;149-168
13. Chaplain M.A.J., Giles S.M., Sleeman B.D., Jarvis R.J. A mathematical model for tumour angiogenesis. J. Math. Biol. 33:1995;744-770
14. Currie M.J., Gunningham S.P., Turner K., Han C., Scott P.A.E., Robinson B.A., Chong W., Harris A.L., Fox S.B. Expression of the angiopoietins and their receptor Tie-2 in human renal clear cell carcinomas; regulation by the von Hippel-Landau gene and hypoxia. J. Pathol. 198:2002;502-510
15. Davis B. Reinforced random walk. Probab. Theor. Rel. Fields. 84:1990;203-229
16. Davis S., Aldrich T.H, Jones P.F, Acheson A., Compton D.L., Jain V., Ryan T.E., Bruno J., Radziejewski C., Maisonpierre P.C., Yancopoulos G.D. Isolation of angiopoietin-1, a ligand for the Tie-2 receptor, by secretion-trap expression cloning. Cell. 87:1996;1161-1169
17. Denekamp J., Hobson B. Endothelial cell proliferation in experimental tumours. Br. J. Cancer. 46:1982;711-720
18. Folkman J. Tumour angiogenesis. therapeutic implications New Engl. J. Med. 285:1971;1182-1186
19. Folkman J., Klagsbrun M. Angiogenic factors. Science. 235:1987;442-447
20. Gale N.W., Thurston G., Hackett S.F., Renard R., Wang Q., McClain J., Martin C., Witte C., Witte M.H., Jackson D., Suri C., Campochiaro P.A., Wiegand S.J., Yancopoulos G.D. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning and only the latter role is rescued by Angiopoietin-1. Dev. Cell. 3:2002;411-423
21. Hackett S.F., Ozaki H., Strauss R.W., Wahlin K., Suri C., Maisonpierre P., Yancopoulos G., Campochiaro P.A. Angiopoietin-2 expression in the retina: upregulation during physiologic and pathologic neovascularisation. J. Cell Physiol. 184:2000;275-284
22. Han Z.C., Liu Y. Angiogenesis. state of the art Int. J. Haematol. 70:1999;68-82
23. Harfouche R., Hassessian H.M., Guo Y., Faivre V., Srikant C.B., Yancopoulos G.D., Hussain S.N.A. Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells. Microvasc. Res. 64:2002;135-147
24. Holash J., Wiegand S.J., Yancopoulos G.D. New model of tumour angiogenesis. dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF Oncogene. 18:1999;5356-5362
25. Holmes M.J., Sleeman B.D. A mathematical model of tumour angiogenesis incorporating cellular traction and viscoelastic effects. J. Theor. Biol. 202:2000;95-112
26. Hunt T.K., Knighton D.R., Thakral K.K., Goodson W.H., Andrews W.S. Studies on inflammation and wound healing. angiogenesis and collagen synthesis stimulated in vivo by resident and activated macrophages Surgery. 96:1984;48-54
27. Jones P.F. Tied up (or down?) with angiopoietins. Angiogenesis. 1:1997;38-44
28. Jones P.F. Not just angiogenesis - wider roles for the angiopoietins. J. Pathol. 201:2003;15-27
29. Joussen A.M., Poulaki V., Tsujikawa A., Qin W., Qaum T., Xu Q., Moromizato Y., Bursell S., Wiegand S.J., Rudge J., Ioffe E., Yancopoulos G.D., Adamis A.P. Suppression of diabetic retinopathy with angiopoietin-1. Am. J. Pathol. 160:2002;1683-1693
30. Klagsbrun M., D'Amore P.A. Vascular endothelial growth factor and its receptors. Cytokine Growth Fact. Rev. 7:1996;259-270
31. Lauffenburger D.A., Zigmond S.H. Chemotactic factor concentration gradients in chemotaxis assay systems. J. Immunol. Meth. 40:1981;45-60
32. Lauren J., Gunji Y., Alitalo K. Is angiopoietin-2 necessary for the initiation of tumour angiogenesis? Am. J. Pathol. 153:1998;1333-1339
33. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306-1309
34. Levine H.A., Sleeman B.D., Nilsen-Hamilton M. A mathematical model of the roles of pericytes and macrophages in the initiation of angiogenesis. I. The role of protease inhibitors in preventing angiogenesis Math. Biosci. 168:2000;77-115
35. Levine H.A., Pamuk S., Sleeman B.D., Nilsen-Hamilton M. A mathematical model of capillary formation and development in tumour angiogenesis: penetration into the stroma. Bull. Math. Biol. 63:2001;801-863
36. Levine H.A., Sleeman B.D., Nilsen-Hamilton M. Mathematical modelling of the onset of capillary formation initiating angiogenesis. J. Math. Biol. 42:2001;195-238
37. Liotta L.A., Steeg P.S., Stetler-Stevenson W.G. Cancer metastasis and angiogenesis. an imbalance of positive and negative regulation Cell. 64:1991;327-336
38. Lobov I.B., Brooks P.C., Lang R.A. Angiopoietin-2 displays vascular endothelial growth factor-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc. Natl. Acad. Sci. USA. 99:2002;11205-11210
39. Loughna S., Sato T.N. Angiopoietin and Tie signalling pathways in vascular development. Matrix Biol. 20:2001;319-325
40. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., Compton D., McClain J., Aldrich T.H., Papandopoulos N., Daly T.J., Davis S., Sato T.N. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. Science. 277:1997;55-60
41. Oh H., Takagi H., Suzuma K., Otani A., Matsumura M., Honda Y. Hypoxia and vascular endothelial growth factor selectively upregulate angiopoietin-2 in bovine microvascular endothelial cells. J. Biol. Chem. 274:1999;15732-15739
42. Othmer H.G., Stevens A. Aggregation, blowup and collapse. the ABC's of taxis and reinforced random walks SIAM J. Appl. Math. 57:1997;1044-1081
43. Papetti M., Herman I.M. Mechanisms of normal and tumour-derived angiogenesis. Am. J. Physiol. Cell Physiol. 282:2002;C947-C970
44. Patan S. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodelling. J. Neuro-Oncol. 50:2000;1-15
45. Paweletz N., Kneirim M. Tumour-related angiogenesis. Crit. Rev. Oncol. Haematol. 9:1989;197-242
46. Pepper M.S. Manipulating angiogenesis. Arteriosis Thromb. Vasc. Biol. 17:1997;605-619
47. Pepper M.S. Extracellular proteolysis and angiogenesis. Thromb. Haemostasis. 86:2001;346-355
48. Plank M.J., Sleeman B.D. A reinforced random walk model of tumour angiogenesis and anti-angiogenic strategies. IMA J. Math. Med. Biol. 20:2003;135-181
49. Plank M.J., Sleeman B.D., Jones P.F. A mathematical model of an in vitro experiment to investigate endothelial cell migration. J. Theor. Med. 4:2003;251-270
50. Reynolds L.P., Killilea S.D., Redmer D.A. Angiogenesis in the female reproductive cycle. FASEB J. 6:1992;886-892
51. Risau V. Mechanisms of angiogenesis. Nature. 386:1997;671-674
52. Schirrmacher V. Cancer metastasis. experimental approaches, theoretical concepts and impacts for treatment strategies Adv. Cancer Res. 43:1985;1-73
53. Sfiligoi C., Luca A.De., Cascone I., Sorbello V., Fuso L., Ponzone R., Biglia N., Audero E., Arisio R., Bussolino F., Sismondi P., Bortoli M.De. Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival. Int. J. Cancer. 103:2003;466-474
54. Shing Y., Folkman J., Sullivan R., Butterfield C., Murray J., Klagsbrun M. Heparin affinity. purification of a tumour-derived capillary endothelial cell growth factor Science. 223:1984;1296-1299
55. Sholley M.M., Ferguson G.P., Seibel H.R., Montour J.L., Wilson J.D. Mechanisms of neovascularisation. Lab. Invest. 51:1984;624-634
56. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359:1992;843-845
57. Sleeman B.D., Wallis I.P. Tumour induced angiogenesis as a reinforced random walk: modelling capillary network formation without endothelial cell proliferation. J. Math. Comp. Modelling. 36:2002;339-358
58. Stokes C.L., Lauffenburger D.A. Analysis of the roles of microvessel endothelial cell random motility and chemotaxis in angiogenesis. J. Theor. Biol. 152:1991;377-403
59. Stratmann A., Risau W., Plate K.H. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol. 153:1998;1459-1466
60. Sundberg C., Kowanetz M., Brown L.F., Detmar M., Dvorak H.F. Stable expression of angiopoietin-1 and other markers by cultured pericytes. phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo Lab. Invest. 82:2002;387-401
61. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the Tie-2 receptor, during embryonic angiogenesis. Cell. 87:1996;1171-1180
62. Tanaka F., Ishikawa S., Yanagihara K., Miyahara R., Kawano Y., Li M., Otake Y., Wada H. Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Cancer Res. 62:2002;7124-7129
63. Thurston G. Complementary actions of vascular endothelial growth factor and angiopoietin-1 on blood vessel growth and leakage. J. Anat. 200:2002;575-580
64. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., Glazer N., Holash J., McDonald D.M., Yancopoulos G.D. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nature Med. 6:2000;460-463
65. Turner S., Sherratt J.A. Intercellular adhesion and cancer invasion: a discrete simulation using the extended Potts model. J. Theor. Biol. 216:2002;85-100
66. Uemura A., Ogawa M., Hirashima M., Fujiwara T., Koyama S., Takagi H., Honda Y., Wiegand S.J., Yancopoulos G.D., Nishikawa S.I. Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J. Clin. Invest. 110:2002;1619-1628
67. Unemori E.N., Ferrara N., Bauer E.A., Amento E.P. Vascular endothelial growth factor induces interstital collagenase expression in human endothelial cells. J. Cell Physiol. 153:1992;557-562
68. Vajkoczy P., Farhadi M., Gaumann A., Heidenreich R., Erber R., Wunder A., Tonn J.C., Menger M.D., Breier G. Microtumour growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2 and angiopoietin-2. J. Clin. Invest. 109:2002;777-785
69. Walsh D.A. Angiogenesis and arthritis. Rheumatology. 38:1999;103-112
70. Witzenbichler B., Maisonpierre P.C., Jones P., Yancopoulos G.D., Isner J.M. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie-2. J. Biol. Chem. 273:1998;18514-18521
71. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 407:2000;242-249
72. Zagzag D., Hooper A., Friedlander D.R., Chan W., Holash J., Wiegand S.J., Yancopoulos G.D., Grumet M. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumour angiogenesis. Exp. Neurol. 159:1999;391-400